Search research articles
Contact Us
Filters
Showing results (531-540 of 586) with videos related to
Page
of 59
Sort By:
Journal of AHIMA
|
October 28, 2011
Teaching the future: an educational response to the AHIMA core model
Bonnie S Cassidy, Valerie J M Watzlaf, Ellen Shakespeare Karl, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 12, 2018
Labeling of Phosphatidylinositol Lipid Products in Cells through Metabolic Engineering by Using a Clickable myo-Inositol Probe
Tanei J Ricks, Chelsi D Cassilly, Adam J Carr, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Alpha(2) adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethyl)oxazoles and -thiazoles
R E Boyd, J B Press, C R Rasmussen, et al.
Cancer Research
|
November 6, 2009
Microenvironmental independence associated with tumor progression
Alexander R A Anderson, Mohamed Hassanein, Kevin M Branch, et al.
The Journal of Cell Biology
|
November 13, 2002
A novel role for p120 catenin in E-cadherin function
Renee C Ireton, Michael A Davis, Jolanda van Hengel, et al.
AJNR. American Journal of Neuroradiology
|
June 15, 2019
Quantification of DTI in the Pediatric Spinal Cord: Application to Clinical Evaluation in a Healthy Patient Population
B B Reynolds, S By, Q R Weinberg, et al.
Cancer Cell
|
April 13, 2011
Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene
Douglas B Stairs, Lauren J Bayne, Ben Rhoades, et al.
Cell and Tissue Banking
|
July 1, 2010
The national DBS brain tissue network pilot study: need for more tissue and more standardization
V Vedam-Mai, N Krock, M Ullman, et al.
Journal of Cell Science
|
November 11, 2010
Xenopus Kazrin interacts with ARVCF-catenin, spectrin and p190B RhoGAP, and modulates RhoA activity and epithelial integrity
Kyucheol Cho, Travis G Vaught, Hong Ji, et al.
The Journal of Clinical Investigation
|
November 14, 2017
p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia
Sarah P Short, Jumpei Kondo, Whitney G Smalley-Freed, et al.
Page
of 59
Search research articles
Search
Showing results (531-540 of 586) with videos related to
Sort By:
Page
of 59
Journal of AHIMA
|
October 28, 2011
Teaching the future: an educational response to the AHIMA core model
Bonnie S Cassidy, Valerie J M Watzlaf, Ellen Shakespeare Karl, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 12, 2018
Labeling of Phosphatidylinositol Lipid Products in Cells through Metabolic Engineering by Using a Clickable myo-Inositol Probe
Tanei J Ricks, Chelsi D Cassilly, Adam J Carr, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Alpha(2) adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethyl)oxazoles and -thiazoles
R E Boyd, J B Press, C R Rasmussen, et al.
Cancer Research
|
November 6, 2009
Microenvironmental independence associated with tumor progression
Alexander R A Anderson, Mohamed Hassanein, Kevin M Branch, et al.
The Journal of Cell Biology
|
November 13, 2002
A novel role for p120 catenin in E-cadherin function
Renee C Ireton, Michael A Davis, Jolanda van Hengel, et al.
AJNR. American Journal of Neuroradiology
|
June 15, 2019
Quantification of DTI in the Pediatric Spinal Cord: Application to Clinical Evaluation in a Healthy Patient Population
B B Reynolds, S By, Q R Weinberg, et al.
Cancer Cell
|
April 13, 2011
Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene
Douglas B Stairs, Lauren J Bayne, Ben Rhoades, et al.
Cell and Tissue Banking
|
July 1, 2010
The national DBS brain tissue network pilot study: need for more tissue and more standardization
V Vedam-Mai, N Krock, M Ullman, et al.
Journal of Cell Science
|
November 11, 2010
Xenopus Kazrin interacts with ARVCF-catenin, spectrin and p190B RhoGAP, and modulates RhoA activity and epithelial integrity
Kyucheol Cho, Travis G Vaught, Hong Ji, et al.
The Journal of Clinical Investigation
|
November 14, 2017
p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia
Sarah P Short, Jumpei Kondo, Whitney G Smalley-Freed, et al.
Page
of 59